DarDoc Research

GLP-1 Trial & Approval Tracker

Compare GLP-1 trial arms

Compare results within a trial or inspect the context behind results from different studies.

STEP UP

Wegovy injection

Without diabetes · 72 weeks · n=1,407

Double-blind, active- and placebo-controlled. Treatment-policy estimand.

Mean body weight change at 72 weeks
  • Semaglutide 7.2 mg−18.7%
  • Semaglutide 2.4 mg−15.6%
  • Placebo−3.9%
Published paper PubMed abstract NCT05646706

A direct comparison uses arms from the same trial. Switch to Two studies to inspect the context behind separate results.